In last trading session, Vivos Therapeutics Inc (NASDAQ:VVOS) saw 0.3 million shares changing hands with its beta currently measuring 7.59. Company’s recent per share price level of $3.09 trading at $0.25 or 8.80% at ring of the bell on the day assigns it a market valuation of $14.72M. That closing price of VVOS’s stock is at a discount of -1478.96% from its 52-week high price of $48.79 and is indicating a premium of 38.19% from its 52-week low price of $1.91. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.12 million shares which gives us an average trading volume of 1.33 million if we extend that period to 3-months.

Vivos Therapeutics Inc (NASDAQ:VVOS) trade information

Upright in the green during last session for gaining 8.80%, in the last five days VVOS remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $3.09 price level, adding 4.92% to its value on the day. Vivos Therapeutics Inc’s shares saw a change of -75.16% in year-to-date performance and have moved 15.30% in past 5-day. Vivos Therapeutics Inc (NASDAQ:VVOS) showed a performance of 33.77% in past 30-days. Number of shares sold short was 69756.0 shares which calculate 0.02 days to cover the short interests.

Vivos Therapeutics Inc (VVOS) estimates and forecasts

Statistics highlight that Vivos Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 45.41% of value to its shares in past 6 months, showing an annual growth rate of 75.98% while that of industry is 18.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 3.00% during past 5 years.

Vivos Therapeutics Inc (NASDAQ:VVOS)’s Major holders

Insiders are in possession of 1.54% of company’s total shares while institution are holding 12.14 percent of that, with stock having share float percentage of 12.33%. Investors also watch the number of corporate investors in a company very closely, which is 12.14% institutions for Vivos Therapeutics Inc that are currently holding shares of the company.